Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ischemic Heart Disease

  Free Subscription

Articles published in
Thromb Haemost
    August 2017
  1. ZAFAR MU, Zafar M, Baber U, Smith DA, et al
    Antithrombotic potency of ticagrelor versus clopidogrel in type-2 diabetic patients with cardiovascular disease.
    Thromb Haemost. 2017;117.
    >> Share

  2. ANETSBERGER A, Blobner M, Haller B, Schmid S, et al
    Immature platelets as a novel biomarker for adverse cardiovascular events in patients after non-cardiac surgery.
    Thromb Haemost. 2017;117.
    >> Share

    July 2017
  3. HARADA Y, Michel J, Lohaus R, Mayer K, et al
    Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents.
    Thromb Haemost. 2017;117.
    >> Share

  4. SILLER-MATULA J, Lang IM, Schoergenhofer C, Roest M, et al
    Interdependence between osteoprotegerin and active von Willebrand factor in long-term cardiovascular mortality prediction in patients undergoing percutaneous coronary intervention.
    Thromb Haemost. 2017;117.
    >> Share

    June 2017
  5. CUBEDO J, Blasco A, Padro T, Ramaiola I, et al
    Molecular signature of coronary stent thrombosis: oxidative stress and innate immunity cells.
    Thromb Haemost. 2017;117.
    >> Share

  6. TEN CATE H, Hackeng TM, Garcia de Frutos P
    Coagulation factor and protease pathways in thrombosis and cardiovascular disease.
    Thromb Haemost. 2017;117:1265-1271.
    >> Share

  7. SIBBING D, Angiolillo DJ, Huber K
    Antithrombotic therapy for acute coronary syndrome: Past, present and future.
    Thromb Haemost. 2017;117:1240-1248.
    >> Share

  8. PREISSNER KT, Herwald H
    Extracellular nucleic acids in immunity and cardiovascular responses: between alert and disease.
    Thromb Haemost. 2017;117:1272-1282.
    >> Share

    April 2017
  9. CHRISTERSSON C, Thulin A, Siegbahn A
    Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events.
    Thromb Haemost. 2017 Apr 20. doi: 10.1160/TH16-11-0837.
    >> Share

    March 2017
  10. CAMPO G, Vieceli Dalla Sega F, Pavasini R, Aquila G, et al
    Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease.
    Thromb Haemost. 2017 Mar 23. doi: 10.1160/TH16-12-0973.
    >> Share

  11. THOMAS MR, Angiolillo DJ, Bonaca MP, Ajjan RA, et al
    Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetes status.
    Thromb Haemost. 2017 Mar 16. doi: 10.1160/TH16-09-0703.
    >> Share

  12. TARANCON-DIEZ L, De Pablo-Bernal RS, Alvarez-Rios AI, Rosado-Sanchez I, et al
    CCR5+ CD8 T-cell levels and monocyte activation precede the onset of acute coronary syndrome in HIV-infected patients on antiretroviral therapy.
    Thromb Haemost. 2017 Mar 9. doi: 10.1160/TH16-11-0867.
    >> Share

    February 2017

  13. Erratum to Rutten et al. "Platelet density per monocyte predicts adverse events in patients after percutaneous coronary intervention" (Thromb Haemost 2016; 115: 353-360).
    Thromb Haemost. 2017;117:641.
    >> Share

  14. URBANSKI K, Ludew D, Filip G, Filip M, et al
    CD14+CD16++ "nonclassical" monocytes are associated with endothelial dysfunction in patients with coronary artery disease.
    Thromb Haemost. 2017 Feb 23. doi: 10.1160/TH16-08-0614.
    >> Share

  15. ALLAN V, Honarbakhsh S, Casas JP, Wallace J, et al
    Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population based cohorts of 20 million participants.
    Thromb Haemost. 2017 Feb 23. doi: 10.1160/TH16-11-0825.
    >> Share

  16. FREYNHOFER MK, Iliev L, Bruno V, Rohla M, et al
    Platelet turnover predicts outcome after coronary intervention.
    Thromb Haemost. 2017 Feb 23. doi: 10.1160/TH16-10-0785.
    >> Share

  17. NIEZGODA P, Sikora J, Baranska M, Sikora A, et al
    Crushed sublingual versus oral ticagrelor administration strategies in patients with unstable angina. A pharmacokinetic/pharmacodynamic study.
    Thromb Haemost. 2017 Feb 16. doi: 10.1160/TH16-08-0670.
    >> Share

  18. PARK Y, Tantry US, Koh JS, Ahn JH, et al
    Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial.
    Thromb Haemost. 2017 Feb 2. doi: 10.1160/TH16-10-0744.
    >> Share

  19. ASHER E, Frydman S, Katz M, Regev E, et al
    Chewing versus Swallowing Ticagrelor to Accelerate Platelet Inhibitionin Acute Coronary Syndrome - the CHEERS study. For The PLATIS (Platelets and Thrombosis in Sheba) Study Group.
    Thromb Haemost. 2017 Feb 2. doi: 10.1160/TH16-09-0728.
    >> Share

    December 2016
  20. ZAKAI NA, McClure LA, Judd SE, Kissela B, et al
    D-dimer and the Risk of Stroke and Coronary Heart Disease. The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
    Thromb Haemost. 2016 Dec 22. doi: 10.1160/TH16-07-0519.
    >> Share

  21. GAO J, Ma X, Zhang Y, Guo M, et al
    The role of microRNAs in prethrombotic status associated with coronary artery disease.
    Thromb Haemost. 2016 Dec 22. doi: 10.1160/TH16-07-0503.
    >> Share

    November 2016
  22. SCHOOLING CM, Zhong Y
    Plasma levels of the anti-coagulation protein C and the risk of ischaemic heart disease. A Mendelian randomisation study.
    Thromb Haemost. 2016.
    >> Share

  23. KREUTZ RP, Schmeisser G, Maatman B, Schaffter A, et al
    Fibrin clot strength measured by thrombelastography and outcomes after percutaneous coronary intervention.
    Thromb Haemost. 2016.
    >> Share

    October 2016
  24. POURDJABBAR A, Hibbert B, Chong AY, Le May MR, et al
    A randomised study for optimising crossover from ticagrelor to clopidogrel in patients with acute coronary syndrome. The CAPITAL OPTI-CROSS Study.
    Thromb Haemost. 2016;117.
    >> Share

  25. FLIERL U, Zauner F, Sieweke JT, Berliner C, et al
    Efficacy of prasugrel administration immediately after percutaneous coronary intervention in ST-elevation myocardial infarction.
    Thromb Haemost. 2016;117.
    >> Share

    September 2016
  26. SIBBING D, Aradi D, Jacobshagen C, Gross L, et al
    A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on chronic Antiplatelet Treatment for Acute Coronary Syndr
    Thromb Haemost. 2016;117.
    >> Share

  27. DARWICHE W, Bejan-Angoulvant T, Angoulvant D, Babuty D, et al
    Risk of myocardial infarction and death in patients with atrial fibrillation treated with dabigatran or vitamin K antagonists. Meta-analysis of observational analyses.
    Thromb Haemost. 2016;116.
    >> Share

    July 2016
  28. WEBER C, Shantsila E, Hristov M, Caligiuri G, et al
    Role and analysis of monocyte subsets in cardiovascular disease. Joint consensus document of the European Society of Cardiology (ESC) Working Groups "Atherosclerosis & Vascular Biology" and "Thrombosis".
    Thromb Haemost. 2016;116.
    >> Share

  29. ANTIOCHOS P, Marques-Vidal P, Virzi J, Pagano S, et al
    Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population. Results from the CoLaus study.
    Thromb Haemost. 2016;116.
    >> Share

    May 2016
  30. SANTILLI F, Marchisio M, Lanuti P, Boccatonda A, et al
    Microparticles as new markers of cardiovascular risk in diabetes and beyond.
    Thromb Haemost. 2016;116.
    >> Share

    March 2016
  31. WHITE SJ, Newby AC, Johnson TW
    Endothelial erosion of plaques as a substrate for coronary thrombosis.
    Thromb Haemost. 2016;115:509-19.
    >> Share

  32. MORBIDUCCI U, Kok AM, Kwak BR, Stone PH, et al
    Atherosclerosis at arterial bifurcations: evidence for the role of haemodynamics and geometry.
    Thromb Haemost. 2016;115:484-92.
    >> Share

    January 2016
  33. KIM JS, Han DC, Jeong YH, Park DW, et al
    Antiplatelet effect of ticagrelor compared to tirofiban in non-ST-segment elevation ACS patients undergoing PCI. The result of the TE-CLOT trial.
    Thromb Haemost. 2016;115:213-21.
    >> Share

  34. POHL J, Hendgen-Cotta UB, Rammos C, Luedike P, et al
    Targeted intracellular accumulation of macrophage migration inhibitory factor in the reperfused heart mediates cardioprotection.
    Thromb Haemost. 2016;115:200-12.
    >> Share

  35. HERTLE E, Arts IC, van der Kallen CJ, Feskens EJ, et al
    The alternative complement pathway is longitudinally associated with adverse cardiovascular outcomes. The CODAM study.
    Thromb Haemost. 2016;115:446-57.
    >> Share

  36. ASHER E, Fefer P, Sabbag A, Herscovici R, et al
    Prior chronic clopidogrel therapy is associated with increased adverse events and early stent thrombosis.
    Thromb Haemost. 2016;115:433-8.
    >> Share

  37. VERGALLO R, Aguirre AD, Abtahian F, Minami Y, et al
    Recurrent myocardial infarctions and premature coronary atherosclerosis in a 23-year-old man with antiphospholipid syndrome.
    Thromb Haemost. 2016;115:237-9.
    >> Share

  38. COLLET JP, Kerneis M, Hulot JS, O'Connor SA, et al
    Point-of-care genetic profiling and/or platelet function testing in acute coronary syndrome.
    Thromb Haemost. 2016;115:382-91.
    >> Share

  39. RUTTEN B, Roest M, McClellan EA, Sels JW, et al
    Platelet density per monocyte predicts adverse events in patients after percutaneous coronary intervention.
    Thromb Haemost. 2016;115:353-60.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016